Jinghua Pharmaceutical Group Co Ltd. Stock Analysis 002349.SZ

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese patent medicine preparations, chemical raw materials and intermediates, chemical and pharmaceutical intermediates, Chinese herbal medicines, and biological pharmaceuticals. The company is headquartered in Nantong, Jiangsu and currently employs 1,462 full-time employees. The company went IPO on 2010-02-03. The firm's main business involves the research and development, production and sales of traditional Chinese patent medicine preparations, chemical raw materials and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal materials and Chinese herbal decoction pieces, and others. The firm's products include Wang's Baochi Pills, Jidesheng Snake Tablets, Zhengchaihu Yin Granules, Astragalus Effervescent Tablets, phenobarbital, fluorouracil, dioxane, methylhydrazine, Angelica Sinensis, and White Peony Root, and others. The firm mainly operates its businesses in the domestic market.